Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Primary Care Diabetes|July 6, 2014
Sialic acid and incidence of hospitalization for diabetes and its complications during 40-years of follow-up in a large cohort: the Värmland surveyPayam Khalili, Johan Sundström, Johan Jendle, et al.
Endocrinology, Diabetes & Metabolism|April 23, 2019
Heart rate variability in type 2 diabetic subjects randomized to liraglutide or glimepiride treatment, both in combination with metformin: A randomized, open, parallel-group studyThomas Nyström, Irene Santos-Pardo, Xin Fang, et al.
Diabetes Care|March 1, 2003
The impact of smoking on inhaled insulinAnders Himmelmann, Johan Jendle, Anders Mellén, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 11, 2020
Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness AnalysisJohan Jendle, Åsa Ericsson, Jens Gundgaard, et al.
Diabetes/Metabolism Research and Reviews|April 23, 2016
Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial programJohan Jendle, George Grunberger, Thomas Blevins, et al.
Diabetes, Obesity & Metabolism|March 19, 2026
Cost-Effectiveness of Automated Insulin Delivery Systems in Paediatrics, T1D and T2D Adults Across Four Nordic CountriesJohan Jendle, Kirsten Nørgaard, Elina Pimiä, et al.
Scandinavian Journal of Urology and Nephrology|May 13, 2010
Skewed X-chromosome inactivation causing diagnostic misinterpretation in congenital nephrogenic diabetes insipidusMia Faerch, Thomas J Corydon, Søren Rittig, et al.
Lancet (London, England)|May 27, 2015
Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority studyLawrence Blonde, Johan Jendle, Jorge Gross, et al.
Diabetes, Obesity & Metabolism|November 5, 2023
Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetesJarl Hellman, Niels Vaever Hartvig, Anne Kaas, et al.
Diabetes, Obesity & Metabolism|June 3, 2026
Intragastric Balloon Treatment Enhances Weight Maintenance Adjunct to Low-Energy Diet and Group-Based Cognitive Behavioural Therapy: A Randomized Controlled TrialMarije Galavazi, Qays Shahed, Hugo Hesser, et al.
Pageof 9